MetAlert, Inc. (MLRT) Market for Self-actualized Wellness Grows

January 30, 2023 10:20:00
  • Wearable wellness technology innovator MetAlert is revitalizing its brand and increasing its product and services portfolio through M&A and other corporate developments designed to improve the company’s healthcare profile
  • The mortality associated with chronic disease can be ameliorated with the use of wearable devices, along with other healthful practices, and the use of wearable wellness technology is expected to continue at an increasing pace
  • More than 41 million people die of noncommunicable diseases (aka chronic illnesses) each year — 17 million of them before the age of 70, according to the World Health Organization
  • MetAlert’s growing product slate is designed to combine unobtrusive wearability, tracking technology, telehealth communication capabilities, and artificial intelligence, to serve the needs of patients and caregivers

For many people, the beginning of a new year signals a time to renew efforts at self-betterment through increased exercise and other healthful practices. One means of measuring improvements that has become popular in recent years is the use of a pedometer to track the wnumber of the wearer’s “steps” in a given day, and smartwatches have made such wearable devices unobtrusive and easily accessible (https://ibn.fm/rs2hb).

The modern variety in wearable technologies has gained increasing use in part because the devices may enable individuals to self-assess their goals and conditioning without the need to visit to visit medical clinics to obtain physiological data and analyze it for biomedicine, healthcare and…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.